Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HLH-2004 Protocol for Hemophagocytic Lymphohistiocytosis
NCT00334672Phase 3Unknown
- Sponsor
- Children's Cancer and Leukaemia Group
- Start
- Mar 2006
- Primary completion
- Nov 2010
- Modality
- Peptides, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of etoposide, dexamethasone, cyclosporine in hemophagocytic lymphohistiocytosis (HLH), sponsored by Children's Cancer and Leukaemia Group. Status: unknown.
02
Drugs
etoposidedexamethasonecyclosporine
03
Conditions
hemophagocytic lymphohistiocytosis (HLH)
Beyond the preview
Go deeper on NCT00334672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00334672.